| __timestamp | Lantheus Holdings, Inc. | Xenon Pharmaceuticals Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 13673000 | 11768000 |
| Thursday, January 1, 2015 | 14358000 | 15152000 |
| Friday, January 1, 2016 | 12203000 | 19828000 |
| Sunday, January 1, 2017 | 18125000 | 25573000 |
| Monday, January 1, 2018 | 17071000 | 23634000 |
| Tuesday, January 1, 2019 | 20018000 | 38845000 |
| Wednesday, January 1, 2020 | 32788000 | 50523000 |
| Friday, January 1, 2021 | 44966000 | 75463000 |
| Saturday, January 1, 2022 | 311681000 | 105767000 |
| Sunday, January 1, 2023 | 77707000 | 167512000 |
Cracking the code
In the competitive landscape of biotechnology, research and development (R&D) spending is a critical indicator of a company's commitment to innovation. Lantheus Holdings, Inc. and Xenon Pharmaceuticals Inc. have shown distinct trajectories in their R&D investments over the past decade. From 2014 to 2023, Lantheus Holdings increased its R&D expenses by over 470%, peaking in 2022 with a staggering 311 million USD. Meanwhile, Xenon Pharmaceuticals demonstrated a consistent upward trend, culminating in a 2023 expenditure that was 14 times its 2014 level. This strategic allocation of funds underscores each company's dedication to advancing medical breakthroughs. As the biotech sector continues to evolve, these financial commitments highlight the pivotal role of R&D in driving future growth and innovation.
Research and Development Expenses Breakdown: Pfizer Inc. vs Xenon Pharmaceuticals Inc.
Research and Development Expenses Breakdown: Zoetis Inc. vs Lantheus Holdings, Inc.
Research and Development Investment: Regeneron Pharmaceuticals, Inc. vs Xenon Pharmaceuticals Inc.
Who Prioritizes Innovation? R&D Spending Compared for Teva Pharmaceutical Industries Limited and Lantheus Holdings, Inc.
Research and Development Investment: Biogen Inc. vs Lantheus Holdings, Inc.
R&D Spending Showdown: Lantheus Holdings, Inc. vs Madrigal Pharmaceuticals, Inc.
Comparing Innovation Spending: Lantheus Holdings, Inc. and Alpine Immune Sciences, Inc.
Research and Development Investment: Lantheus Holdings, Inc. vs TG Therapeutics, Inc.
R&D Insights: How Lantheus Holdings, Inc. and Amicus Therapeutics, Inc. Allocate Funds
Research and Development Investment: ADMA Biologics, Inc. vs Xenon Pharmaceuticals Inc.
R&D Spending Showdown: CymaBay Therapeutics, Inc. vs Xenon Pharmaceuticals Inc.
Analyzing R&D Budgets: Veracyte, Inc. vs Xenon Pharmaceuticals Inc.